ALBANY, N.Y. - New York state is partnering with a British company in clinical trials for marijuana-based medication for children with medication-resistant seizures.
In an agreement with Gov. Andrew Cuomo's administration, the state health department and GW Pharmaceuticals will develop the framework for trials for a marijuana-based drug for people under age 18.
A state official with knowledge of the agreement spoke to The Associated Press on condition of anonymity because the official wasn't authorized to publicly discuss the matter.
The drug, Epidiolex, uses a marijuana extract that doesn't get users high. But it could help children with rare forms of epilepsy. The trial must be approved by the Food and Drug Administration.
The agreement with GW Pharmaceuticals comes as medical marijuana legislation is being pushed to the forefront of state politics.